idecabtagene vicleucel,pyrotinib
jiangsu hengrui pharmaceuticals,2seventy bio,bms
['idecabtagene', 'thank you', 'irene', 'karmma', 'ide-cel']
(1) both cr and mrd- at 3 months (only mrd- at 1 month) of ide-cel infusion were required to identify pts with longer pfs. (2) reappearence of normal pc as a surrogate of relapse. thank you, ! #ash2022 
Hematologist at Hospital Clínic de Barcelona